HCL Is Key Solutions Provider For BD's New R&D Facility

HCL Is Key Solutions Provider For BD's New R&D Facility

FP Archives February 2, 2017, 23:34:11 IST

BD, the medical technology company, will focus on creating innovative solutions by leveraging HCL’s capabilities and service expertise.

Advertisement
HCL Is Key Solutions Provider For BD's New R&D Facility

BD (Becton, Dickinson and Company), a global medical technology company announced that it has signed an engineering and R&D services (ERS) engagement with HCL Technologies Ltd. (HCL), a global IT services provider. BD also officially inaugurated its first R&D facility in Chennai, Tamil Nadu. This facility is a significant milestone for BD in its efforts to expand its R&D into Asia, and demonstrates its strong relationship with HCL, which began in 2007.

Advertisement

The new facility is part of BD’s efforts to accelerate R&D innovation to develop new products and markets, achieve time-to-market advantage for its products and enhance operational efficiencies. This facility will be directly managed by BD - Singapore.

According to the engagement, BD will focus on creating innovative solutions by leveraging HCL’s capabilities and service expertise such as sustenance engineering and product – testing services delivered out of this facility. HCL will also conduct product life cycle and design verification studies to support new product development initiatives and product launches for BD in the emerging markets, such as India.

“Emerging markets play a key role in addressing the innovation challenges in the healthcare industry, and we continue investing in R&D for market-appropriate solutions,” said Scott P. Bruder M.D. Ph.D., Senior Vice President and Chief Science and Technology Officer, BD. “We value our relationship with HCL, which will help us create new capabilities in the Asia Pacific region and will offer significant support to develop effective and affordable solutions and medical innovations.”

Advertisement

“HCL understands that the critical path for research is not only in developing products but also in harnessing medical innovations in an efficient and effective way,” said G.H. Rao, Senior Corporate Vice President, Engineering and R&D Services, HCL Technologies. “We are proud of our engagement with BD and will continue to power new ideas and help foster innovations. This engagement is yet another testimonial of HCL’s leadership in Engineering and R&D services globally.”

Advertisement
Written by FP Archives

see more

Latest News

Find us on YouTube

Subscribe

Top Shows

Vantage First Sports Fast and Factual Between The Lines